Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately... J Gastroenterol (2017) 52:1079 DOI 10.1007/s00535-017-1340-3 ERRATUM Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis 1 2 3 4 • • • • Yasuo Suzuki Satoshi Motoya Hiroyuki Hanai Toshifumi Hibi 5 6 7 7 • • • • Shiro Nakamura Andreas Lazar Anne Martin Robinson Martha Skup 7 7 7 8 • • • Nael Mohamed Mostafa Bidan Huang Roopal Thakkar Mamoru Watanabe Published online: 12 April 2017 Japanese Society of Gastroenterology 2017 Erratum to: J Gastroenterol Acknowledgements The study was designed, conducted, DOI 10.1007/s00535-017-1325-2 and funded by AbbVie Inc and Eisai Co, Ltd. AbbVie Inc participated in the interpretation of data, review, and The authors would like to correct the error in the publi- approval of the manuscript. Vicki Schwartz and Alessia cation of the original article. The corrected detail is pub- Piazza provided medical writing and editorial support in lished with this erratum for your reading. the preparation of this manuscript, which was funded by AbbVie Inc. The online version of the original article can be found under doi:10.1007/s00535-017-1325-2. & Toshifumi Hibi thibi@insti.kitasato-u.ac.jp Toho University Medical Center Sakura Hospital, Chiba, Japan IBD Center, Sapporo Kosei General Hospital, Sapporo, Japan Hamamatsu South Hospital, Shizuoka, Japan IBD Centre, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan Hyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany AbbVie, Inc., North Chicago, IL, USA Department of Gastroenterology, Tokyo Medical and Dental University, Tokyo, Japan http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Gastroenterology Springer Journals

Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/erratum-to-four-year-maintenance-treatment-with-adalimumab-in-japanese-J9bACTVlQY
Publisher
Springer Japan
Copyright
Copyright © 2017 by Japanese Society of Gastroenterology
Subject
Medicine & Public Health; Gastroenterology; Hepatology; Abdominal Surgery; Colorectal Surgery; Surgical Oncology
ISSN
0944-1174
eISSN
1435-5922
D.O.I.
10.1007/s00535-017-1340-3
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial